BioScrip’s home infusion revenues jump nearly 50%
ELMSFORD, N.Y. – BioScrip has reported revenues of $247.1 million and a net loss of $18.6 million for the second quarter of 2014. Total revenues increased by $74.8 million or 43.4% compared to the same period last year. Revenues from home infusion, specifically, increased $74.6 million or 47.8%. The growth in home infusion was driven primarily by continued strong double-digit organic growth and the acquisition of CarePoint Partners, the company stated.